As of 2023, the mortality rate for respiratory system diseases among females in the US stood at 135.4 thousand deaths. The forecasted data reveals a steady decline in mortality, from 134.02 thousand in 2024 down to 128.63 thousand by 2028. This shows consistent year-on-year reductions, with approximately a 1% annual decrease. The compound annual growth rate (CAGR) over this five-year span signals a notable average decline in mortality, indicating improved healthcare outcomes or preventative measures.
Future trends to monitor include advancements in respiratory disease treatments, public health initiatives aimed at reducing risk factors like smoking, and environmental regulations impacting air quality. Continuous monitoring of these factors will be crucial for assessing ongoing trends in respiratory disease mortality.
